Scientific Programme

Sunday | Monday | Tuesday | Wednesday

ECIO 2018 Preliminary Programme (PDF download 4.87 MB)

 

Sunday, April 22

   
  08:30-10:00
  Clinical Focus Session
CF 101 Colorectal cancer in 2018
   
101.1
 
101.2
 
101.3
 
101.4
101.5
 
101.6
 
Tumour biomarkers and metastatic colorectal cancer
G. Masi (Pisa/IT)
Treatment strategies according to the ESMO guidelines
D. Arnold (Hamburg/DE)
Immunotherapy in metastatic colorectal cancer: present and future
A. Italiano (Bordeaux/FR)
Scientific paper
Local treatment in oligometastatic disease: current role
P.L. Pereira (Heilbronn/DE)
Intra-arterial therapies in liver dominant disease
T. de Baère (Villejuif/FR)
   
   
  10:30-12:00
  Clinical Focus Session
CF 201 Immunotherapy: how does it work
   
201.1
 
201.2
 
201.3
 
201.4
201.5
 
201.6
 
Tumour micro-environment
K. Willard-Gallo (Brussels/BE)
Not all cancers are candidates for immunotherapy: why?
C. Ottensmeier (Southampton/UK)
T-cell therapy: what you need to know
S. Hervás Stubbs (Navarra/ES)
Scientific paper
Tumour vaccination: local vs. systemic
J. Rodríguez (Pamplona/ES)
Radiation and immunotherapy
R. Sharma (London/UK)
   
   
  10:30-12:00
  Technical Focus Session
TF 202 Image guidance: case-based discussion
   
202.1
 
202.2
 
202.3
 
202.4
 
202.5
 
202.6
 
Ultrasound: current and future development
L. Solbiati (Rozzano/IT)
CBCT applications: vascular and non-vascular
M.J.L. van Strijen (Nieuwegein/NL)
Combined angio and CT
B. Guiu (Montpellier/FR)
MR and PET in IO
J. Garnon (Strasbourg/FR)
Robotic and stereotaxic assistance in IO
D. Putzer (Innsbruck/AT)
Hybrid rooms for IO?
G. Carrafiello (Milan/IT)
   
   
  10:30-12:00
  Hands-on Device Training
TA-HDT 1 Tumour ablation - Radiofrequency
   
  Coordinators: T. Sabharwal (London/UK), C.-M. Sommer (Stuttgart/DE)
   
   
  13:00-14:30
  Satellite Symposia
   
   
  15:00-16:30
  Clinical Focus Session
CF 401 Colorectal cancer: role of locoregional therapies
   
401.1
 
 
401.2
 
401.3
401.4
 
401.5
 
401.6
 
The oncologist's point of view: intra-arterial therapies - when, how and what
to expect
G. Masi (Pisa/IT)
Combined analysis of the global FOXFIRE studies
R. Sharma (London/UK)
Scientific paper
Hepatic arterial infusion chemotherapy (HAIC): what are the indications?
Y. Arai (Tokyo/JP)
What is the role of thermal ablation after the CLOCC trial?
T. Ruers (Amsterdam/NL)
The role of ablation in extrahepatic metastasis
T.K. Helmberger (Munich/DE)
   
   
  15:00-16:30
  Clinical Focus Session
CF 402 Recent developments
   
402.1
 
402.2
 
402.3
 
402.4
402.5
 
402.6
 
Drug-eluting particles
I. Bargellini (Pisa/IT)
Drug delivery and HIFU
B.J. Wood (Bethesda, MD/US)
Dosimetry in radioembolisation
E. Garin (Rennes/FR)
Scientific paper
Intratumoural viral therapy
D. Sze (Stanford, CA/US)
Immunotherapy plus ablation or DEB-TACE
R. Lencioni (Miami, FL/US)
   
   
  15:00-16:30
  Hands-on Device Training
TA-HDT 2 Tumour ablation - Radiofrequency
   
  Coordinators: T. Sabharwal (London/UK), C.-M. Sommer (Stuttgart/DE)
   
   
  17:00-18:30
  Clinical Focus Session
CF 501 Neuroendocrine liver metastases
   
501.1
 
501.2
 
501.3
 
501.4
 
501.5
 
Demographics, epidemiology, clinical presentation
to be announced
Patient selection for local therapies
L. Tselikas (Villejuif/FR)
Radionuclide imaging and therapy in neuroendocrine tumours (Theranostics)
B. Drake (Plymouth/UK)
Transarterial therapy: chemoembolisation and bland embolisation
H. Rio Tinto (Lisbon/PT)
Transarterial therapy: radioembolisation
M.G.E.H. Lam (Utrecht/NL)
   
   
  17:00-18:30
  Technical Focus Session
TF 502 Tips and tricks: case-based discussion
   
502.1
 
502.2
 
502.3
 
502.4
 
502.5
 
Kidney cancer: central disease
J.-M. Correas (Paris/FR)
Lung insufficiency and primary cancer
R.D. Suh (Los Angeles, CA/US)
Peripheral liver tumours
M.P. Fürstner (Klagenfurt/AT)
Focal prostate ablation: avoiding rectal injury
J.J. Fütterer (Nijmegen/NL)
Pelvic bone ablation: how to avoid neurological complications
R.F. Grasso (Rome/IT)
   
   
  17:00-19:00
  Basic Course
BC 503 MSK in oncology: Fundamentals of IO in bone and image-guided biopsy
   
503.1
 
503.2
 
503.3
 
Basic diagnostic imaging of bone tumours
A. Feydy (Paris/FR)
Image guidance and needles for bone biopsy
R.L. Cazzato (Strasbourg/FR)
Techniques, tips and tricks for spine, peripheral bones and soft tissues biopsy
D.K. Filippiadis (Athens/GR)
   
   
  18:30-19:00
  Satellite Symposia
   
TOP  
   
   
Monday, April 23
   
  07:45-08:15
  Satellite Symposia
   
   
  08:30-10:00
  Clinical Focus Session
CF 801 Intrahepatic cholangiocarcinoma
   
801.1
 
801.2
 
801.3
 
801.4
 
801.5
 
Demographics, epidemiology, clinical presentation and genetics
M. Marzioni (Ancona/IT)
How to choose among the various liver-directed treatments
B.C. Odisio (Houston, TX/US)
Presurgical management: increasing the future remnant liver
A. Denys (Lausanne/CH)
Percutaneous ablation in cirrhotic and non-cirrhotic patients
A. Hocquelet (Lausanne/CH)
Intra-arterial therapies: the evidence
R. Golfieri (Bologna/IT)
   
   
  08:30-10:00
  Clinical Focus Session
CF 802 Understanding tumour biology
   
802.1
 
802.2
 
802.3
802.4
 
802.5
 
802.6
 
Hypoxia and anoxia – friend or enemy?
R. Duran (Lausanne/CH)
Local procedures inducing tumour spread
M. Ahmed (Boston, MA/US)
Scientific paper 
Post-ablation inflammation and immune reactions – the good
G.J. Adema (Nijmegen/NL)
Post-ablation inflammation and immune reactions – the bad
N. Goldberg (Jerusalem/IL)
Combined locoregional and systemic immunotherapy: clinical results
B.J. Wood (Bethesda, MD/US)
   
   
  10:30-11:30
HL 901 Honorary Lecture
   
 
 
901.1
 
Laudation: J.W. Jennings (St. Louis, MO/US)

Building the IO department for the future
M.R. Callstrom (Rochester, MN/US)
   
   
  10:30-12:00
  Hands-on Device Training
TA-HDT 3 Tumour ablation - Microwave
   
  Coordinators: R.-T. Hoffmann (Dresden/DE), A.J. King (Southampton/UK)
   
   
  11:30-12:00
FP 902 Free Paper Session
   
   
  13:00-14:30
  Satellite Symposia
   
   
  15:00-16:30
  Clinical Focus Session
CF 1101 Lung metastases
   
1101.1
 
1101.2
 
1101.3
 
1101.4
1101.5
 
1101.6
 
Rationale for local treatment
E.F. Smit (Amsterdam/NL)
SBRT: current evidence?
K.U. Dieckmann (Vienna/AT)
Rationale for thermal ablation
R.D. Suh (Los Angeles, CA/US)
Scientific paper 
Technical considerations of thermal ablation
F. Deschamps (Villejuif/FR)
Clinical and imaging follow-up
J. Palussière (Bordeaux/FR)
   
   
  15:00-16:30
  Clinical Focus Session
CF 1102 HCC in 2018
   
1102.1
 
1102.2
 
1102.3
 
1102.4
 
1102.5
1102.6
 
1102.7
 
HCC classifications: a reappraisal
R. Salem (Chicago, IL/US)
Hep. B and Hep. C: where to use antiviral therapy in HCC
N.P. Malek (Tübingen/DE)
Local ablation: which technology
L. Crocetti (Pisa/IT)
Intermediate stage: when radioembolisation should come first?
B. Sangro (Pamplona/ES)
Scientific paper 
Intermediate stage: what are the indications for combined IO therapies?
J. Ricke (Munich/DE)
Immuno-oncology: future directions for HCC
A. Digklia (Lausanne/CH)
   
   
  15:00-16:30
  Hands-on Device Training
TA-HDT 4 Tumour ablation - Microwave
   
  Coordinators: R.-T. Hoffmann (Dresden/DE), A.J. King (Southampton/UK)
   
   
  17:00-18:30
  Clinical Focus Session
CF 1201 IO in HCC: clinical practice
   
1201.1
 
1201.2
 
1201.3
 
1201.4
1201.5
 
1201.6
 
Diagnostic imaging of HCC
C. Ayuso (Barcelona/ES)
Added value of biopsy
V. Paradis (Clichy/FR)
TACE: a critical appraisal of clinical results
K. Malagari (Athens/GR)
Scientific paper 
New techniques in TACE
P. Chevallier (Nice/FR)
Radioembolisation: what has changed with the recent trials?
V. Vilgrain (Clichy/FR)
   
   
  17:00-18:30
  Multidisciplinary Tumour Board
MTB 1202 Primary lung cancer and metastases
   
  Coordinators: T. de Baère (Villejuif/FR), S.B. Solomon (New York, NY/US)
  Panellists: K.U. Dieckmann (Vienna/AT), M. Fuchs (Munich/DE),
T.K. Helmberger (Munich/DE), J. Jougon (Pessac/FR), E.F. Smit (Amsterdam/NL)
   
   
  17:00-19:00
  Basic Course
BC 1203 MSK in oncology: Percutaneous ablation of bone and soft tissue lesions
   
1203.1
 
 
1203.2
 
1203.3
 
1203.4
 
 
Principles, advantages and disadvantages of the ablation techniques (ethanol, laser, RFA, MWA, cryo and HIFU) available for bone tumours
D.K. Filippiadis (Athens/GR)
Basic protective measures to be adopted during bone ablation
D.K. Filippiadis (Athens/GR)
Indications, technique and results for painful benign bone tumours
A. Feydy (Paris/FR)
Algorithm and techniques for malignant bone tumours management (curative vs palliative; associated consolidate treatments)
R.L. Cazzato (Strasbourg/FR)
   
   
  18:30-19:00
  Satellite Symposia
   
TOP  
   
   
Tuesday, April 24
   
  07:45-08:15
  Satellite Symposia
   
   
  08:30-10:00
  Multidisciplinary Tumour Board
MTB 1501 Kidney cancer
   
  Coordinators: D.J. Breen (Southampton/UK), E. de Kerviler (Paris/FR)
  Panellists: M. Bezzi (Rome/IT), T. Nielsen (Aarhus/DK),
M. Schmidinger (Vienna/AT), G. Tsoumakidou (Lausanne/CH)
   
   
  08:30-10:00
  Clinical Focus Session
CF 1502 Immunotherapy in 2018
   
1502.1
 
1502.2
 
 
1502.3
 
1502.4
1502.5
 
 
1502.6
 
Immunoscore: is it more relevant than TNM?
J. Galon (Paris/FR)
Targeting immunogenic cell death with conventional anticancer therapies: are all equally effective? 
to be announced
Gene therapy and interventional oncology: searching for synergism
to be announced
Scientific paper
Local expression of immunostimulating antibodies in the tumour micro-environment: myth or reality? 
C. Smerdou (Pamplona/ES)
Adoptive cell therapy in cancer: a review of clinical applications
to be announced
   
   
  10:30-12:00
  Clinical Focus Session
CF 1601 MSK: curative treatment
   
1601.1
 
1601.2
 
1601.3
 
1601.4
1601.5
 
1601.6
 
Diagnostic imaging and role of biopsy
A.D. Kelekis (Athens/GR)
Bone tumour ablation: which technique and where?
J.W. Jennings (St. Louis, MO/US)
Avoiding neurological complications during ablation
A.N. Kurup (Rochester, MN/US)
Scientific paper
Embolisation combined with ablation: when and where?
A.G. Ryan (Waterford City/IE)
Bone consolidation technique: which technique and where?
X. Buy (Bordeaux/FR)
   
   
  10:30-12:00
  Clinical Focus Session
CF 1602 Safety belts and airbags: complications and how to avoid them
   
1602.1
 
1602.2
 
1602.3
 
1602.4
 
1602.5
 
1602.6
 
Liver thermal ablation
P. Chevallier (Nice/FR)
TACE
Y. Arai (Tokyo/JP)
Radioembolisation
R. Cioni (Pisa/IT)
Kidney ablation
M. Borensztein (Buenos Aires/AR)
Lung ablation
A. Veltri (Orbassano/IT)
Pancreatic ablation
A. Nilsson (Uppsala/SE)
   
   
  10:30-12:00
  Hands-on Device Training
TA-HDT 5 Tumour ablation - Cryoablation and laser ablation
   
  Coordinators: F.M. Gómez (Barcelona/ES), A.H. Mahnken (Marburg/DE)
   
   
  13:00-14:30
  Satellite Symposia
   
   
  15:00-16:30
  Clinical Focus Session
CF 1801 MSK: palliative treatment
   
1801.1
 
1801.2
 
1801.3
 
1801.4
1801.5
 
1801.6
 
Systemic management of pain
R. Breitkopf (Innsbruck/AT)
IO or SBRT: when and where
L.M. Kenny (Brisbane, QLD/AU)
Thermal ablation: with or without consolidation
S. Marcia (Cagliari/IT)
Scientific paper
Embolisation in pain palliation
R.D. Garcia-Mónaco (Buenos Aires/AR)
Percutaneous consolidations: cement, screw …
G. Koch (Strasbourg/FR)
   
   
  15:00-16:30
  Video Learning Session
VL 1802 How I do it
   
1802.1
 
1802.2
 
1802.3
 
1802.4
 
1802.5
 
1802.6
 
1802.7
 
1802.8
 
Lung ablation: anaesthesia and positioning
J. Palussière (Bordeaux/FR)
Multipolar ablation of the liver
O. Seror (Bondy/FR)
Liver radioembolisation in central tumours
A. van den Hoven (Utrecht/NL)
Combined techniques: ablation and embolisation
R. Iezzi (Rome/IT)
Hilar cholangiocarcinoma: preparation for surgery
R. Duran (Lausanne/CH)
Chemosaturation
B. Stedman (Southampton/UK)
Tricky bone biopsy
A. Basile (Catania/IT)
Pancreatic electroporation
G. Narayanan (Miami, FL/US)
   
   
  15:00-16:30
  Hands-on Device Training
TA-HDT 6 Tumour ablation - Image guidance
   
  Coordinators: R. Bale (Innsbruck/AT), L. Solbiati (Rozzano/IT)
   
   
  17:00-18:30
  Clinical Focus Session
CF 1901 Follow-up imaging after intervention: towards consensus
   
1901.1
 
1901.2
 
1901.3
 
1901.4
 
1901.5
 
 
 
Evidence and current practice in thermal ablation for liver metastasis
E. Klompenhouwer (Amsterdam/NL), co-author: M. Maas (Amsterdam/NL)
Evidence and current practice in TACE for liver cancer
P. Vilares Morgado (Porto/PT)
Evidence and current practice in TARE for liver cancer
N. Schäfer (Lausanne/CH)
Evidence and current practice in thermal ablation for lung cancer
J.-Y. Gaubert (Marseille/FR)
Evidence and current practice in thermal ablation for renal cancer
S.B. Solomon (New York, NY/US)
Panel discussion
Conclusions from the expert panel and further directions for clinical practice
   
   
  17:00-18:30
FP 1902 Free Paper Session
   
   
  17:00-19:00
  Basic Course
BC 1903
 
MSK in oncology: Spinal intervention: interventions in vertebral body compression fractures (VBCF)
   
1903.1
 
1903.2
 
1903.3
 
 
Indications, technique and results for vertebroplasty
A. Feydy (Paris/FR)
Indications, technique and results for vertebral augmentation
D.K. Filippiadis (Athens/GR)
Ablation, embolisation, surgery and vertebral augmentation in malignant bone
tumours
R.L. Cazzato (Strasbourg/FR)
   
   
  18:30-19:00
  Satellite Symposia
   
TOP  
   
   
Wednesday, April 25
   
  08:30-10:00
  Clinical Focus Session
CF 2101 Kidney tumours
   
2101.1
 
2101.2
 
2101.3
2101.4
 
2101.5
 
2101.6
 
Guidelines: EAU, ESMO, CIRSE arguments
D.J. Breen (Southampton/UK)
Biopsy in renal ablation: when and how?
G. Tsoumakidou (Lausanne/CH)
Scientific paper
Ablation T1b tumours
E. de Kerviler (Paris/FR)
Evidence-based ablation vs. resection outcomes
T. Nielsen (Aarhus/DK)
Adrenal metastasis ablation
A.J. King (Southampton/UK)
   
   
  08:30-10:00
  Clinical Focus Session
CF 2102
 
The role of local tumour treatment in oligometastatic disease: time for an honest conversation
   
2102.1
 
2102.2
 
2102.3
 
2102.4
 
2102.5
 
2102.6
Oligometastatic disease: does it exist?
T. Treasure (London/UK)
Which patients should receive systemic therapy?
U. Martens (Heilbronn/DE)
Local tumour treatment: the role of the surgeon
C.R. Ferrone (Boston, MA/US)
Interventional oncology: how I select my patients
A. Gillams (London/UK)
SABR, conventional radiotherapy or nothing at all – which choice when?
L.M. Kenny (Brisbane, QLD/AU)
Panel discussion
   
   
  10:00-10:45
  Satellite Symposia
   
   
  11:15-12:45
MM 2201 Morbidity & Mortality Conference
   
  Coordinators: J. Garnon (Strasbourg/FR), J. Golzarian (Minneapolis, MN/US)
   

TOP